CYP1A1 and breast carcinoma: (iv) Synthetic AhR ligands including pharmaceuticals (Figure 2): Initial studies in this laboratory identified MCDF as a partial AhR antagonist which inhibited induction of CYP1A1 by TCDD in cell culture, whereas MCDF exhibited AhR-dependent antiestrogenic activity in the mouse uterus and breast cancer cells.